Top global companies by orphan drug revenues 2023
This statistic displays the top pharmaceutical companies worldwide based on sales revenues generated by orphan drugs in 2023. During that year, Johnson & Johnson was the world's top company, totaling 16.7 billion U.S. dollars in orphan drug sales. Orphan drugs are developed to treat a specific rare medical condition, often called an orphan disease. In many countries, public policy determines the characteristics behind specifying orphan diseases and drugs.
